Search
for
Sort by
Research 30 of 130
- The Risk of Venous Thromboembolism (VTE) in Men with Benign Prostatic Hyperplasia Treated with 5-Alpha Reductase Inhibitors (5ARIs).
- Hormonal contraceptives: pharmacology tailored to women's health
- Venous and pulmonary thromboembolism and combined hormonal contraceptives. Systematic review and meta-analysis
- Association of Surgical Risk With Exogenous Hormone Use in Transgender Patients
- Gender-Affirming Hormone Therapy for Transgender Females
- Is hormonal treatment still an option in acne today?
- Evaluation and Treatment of Gender Dysphoria to Prepare for Gender Confirmation Surgery
- Hormonal, Medical, and Nonsurgical Aspects of Gender Affirmation
- Use of combined oral contraceptives and risk of venous thromboembolism in young women: a nested case–control analysis using German claims data
- 52309 Association of venous thromboembolism in patients with alopecia areata
- Markers of Venous Thromboembolism Risk in Patients with Alopecia Areata: Is There Anything to Worry about?
- PD49-03 IS TADALAFIL ASSOCIATED WITH DECREASED RISK OF MAJOR ADVERSE CARDIAC EVENTS OR VENOUS THROMBOEMBOLISM IN MEN WITH LOWER URINARY TRACT SYMPTOMS?
- Contraceptive implants considered 'safe'
- Combined hormonal contraception and venous thromboembolism
- Glucocorticoids and Risk of Venous Thromboembolism in Asthma Patients Aged 20–59 Years in the United Kingdom’s CPRD 1995–2015
- Alopecia areata does not increase the risk of venous thromboembolism: an All of Us case-control study
- Venous thromboembolism and women's health
- Clinical characteristics and outcomes of patients with superficial venous thrombosis at multiple sites simultaneously
- Building a Better Scar: Re-engineering Extracellular Matrix Structure in Dermal Scars
- A Need for Government Intervention? Prescription Drug Prices and Retail Mark-Ups
- Developmental Regulation of Prion Expression in Cattle and Mouse Embryonic Stem Cells
- Update: baricitinib for alopecia areata
- Baricitinib Provides Significant Hair Regrowth In Adolescents With Severe Alopecia Areata: 52-Week Efficacy and Safety Results From A Phase 3 Randomized, Controlled Trial
- Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7
- Acne, the Skin Microbiome, and Antibiotic Treatment
- Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms
- The Role of Micronutrients in Alopecia Areata: A Review
- Modulatory role of vitamins A, B3, C, D, and E on skin health, immunity, microbiome, and diseases
- Endocrine care of transpeople part I. A review of cross-sex hormonal treatments, outcomes and adverse effects in transmen
- Adult skin acute stress responses to short‐term environmental and internal aggression from exposome factors